Abnormalities Clinical Trials

56 recruitingLast updated: July 25, 2026

There are 56 actively recruiting abnormalities clinical trials across 29 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 4, Phase 1. Top locations include Philadelphia, Pennsylvania, United States, Hong Kong, Hong Kong, Atlanta, Georgia, United States. Updated daily from ClinicalTrials.gov.


Abnormalities Trials at a Glance

56 actively recruiting trials for abnormalities are listed on ClinicalTrialsFinder across 6 cities in 29 countries. The largest study group is Not Applicable with 16 trials, with the heaviest enrollment activity in Philadelphia, Hong Kong, and Atlanta. Lead sponsors running abnormalities studies include Chinese University of Hong Kong, Mayo Clinic, and Arizona State University.

Browse abnormalities trials by phase

Treatments under study

About Abnormalities Clinical Trials

Looking for clinical trials for Abnormalities? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Abnormalities trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Abnormalities clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 56 trials

Recruiting
Phase 3

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

Interstitial Lung DiseasesFamilial Pulmonary FibrosisInterstitial Lung Abnormalities
Boehringer Ingelheim80 enrolled56 locationsNCT07201922
Recruiting

A Prospective Natural History Study of Lymphatic Anomalies

Lymphatic AbnormalitiesLymphatic Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1,200 enrolled2 locationsNCT05731141
Recruiting

MRI Study of Musculoskeletal Function

Patellofemoral Pain SyndromeAbnormalitiesImaging
National Institutes of Health Clinical Center (CC)750 enrolled1 locationNCT00051857
Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Hodgkin LymphomaNon-Hodgkin LymphomaHematologic Malignancies+14 more
Center for International Blood and Marrow Transplant Research99,999 enrolled142 locationsNCT01351545
Recruiting
Not Applicable

(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000

Dry Age-Related Macular DegenerationEpiretinal MembraneMacular Abnormalities+7 more
Carl Zeiss Meditec-Dublin CoCe400 enrolled6 locationsNCT07680244
Recruiting
Not Applicable

Transcriptomic Approach for the Identification and Prioritization of Genome Variants in Neurodevelopmental Disorders With Malformation

Neurodevelopmental Disorders and Developmental Abnormalities
University Hospital, Angers58 enrolled7 locationsNCT06762678
Recruiting
Phase 3

Statins Study in Children of Acute Kawasaki Disease With Coronary Artery Abnormalities

Kawasaki DiseaseCoronary Artery Abnormalities
Children's Hospital of Fudan University9 enrolled1 locationNCT07530640
Recruiting

Orthognathic Speech Pathology: Phonetic Contrasts of Patients With Dental Discrepancies Pre- and Post-Treatment Analyses

Speech DisordersDentofacial DeformitiesSpeech Sound Disorder+7 more
University of North Carolina, Chapel Hill180 enrolled1 locationNCT04117360
Recruiting

The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment

AneuploidyDown Syndrome (Trisomy 21)22q11.2 Deletion Syndrome+4 more
BillionToOne Inc.1,000 enrolled6 locationsNCT07643896
Recruiting
Phase 4

GLP-1R Actions on Muscle and the Skeleton

ObesityOsteoporosisDrug Effect+2 more
Pennington Biomedical Research Center50 enrolled1 locationNCT07154719
Recruiting
Phase 3

Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)

Muscular Dystrophy, DuchenneDMDNeuromuscular Diseases (NMD)+10 more
Dyne Therapeutics90 enrolled1 locationNCT07608432
Recruiting
Phase 2

Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

HPV InfectionASC-USUterine Cervical Dysplasia+3 more
Amplexd Therapeutics, Inc.45 enrolled1 locationNCT07572396
Recruiting
Not Applicable

Effectiveness of the COPCA Program in Infants at Risk of Neurodevelopmental Disorders

Neurodevelopmental DisordersNeurodevelopmental Disorders and Developmental Abnormalities
University of Seville40 enrolled1 locationNCT07387627
Recruiting

Mayo AVC Registry and Biobank

CardiomyopathiesCardiovascular DiseasesSarcoidosis+14 more
Mayo Clinic1,000 enrolled2 locationsNCT03049254
Recruiting
Not Applicable

Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDH

HerniaCongenital Diaphragmatic HerniaInternal Hernia+5 more
Johns Hopkins University80 enrolled1 locationNCT07166172
Recruiting

The Combined First Trimester Screening

Fetal Growth RestrictionPreterm LaborPreeclampsia (PE)+4 more
Institute of Health Information and Statistics of the Czech Republic2,000 enrolled3 locationsNCT07015203
Recruiting
Not Applicable

Visual Influences on Vestibular Adaptation

Vestibular HypofunctionBinocular Vision AbnormalitiesReduced Vision
Emory University100 enrolled2 locationsNCT07380256
Recruiting

Mayo Clinic Upper Digestive Disease Survey

Esophageal CancerEsophagus CancerEsophageal Neoplasms+6 more
Mayo Clinic1,000 enrolled1 locationNCT02530983
Recruiting

Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders

Traumatic Brain Injury (TBI)Hypoxic-ischemic encephalopathy (HIE)Williams Syndrome+20 more
Healing Hope International100 enrolled1 locationNCT07493096
Recruiting

The effect of standardised pathway on the diagnosis and management of platelet-related bleeding disorders.

Inherited abnormalities in platelet number or platelet function.
Northern Sydney Local Health District350 enrolled1 locationACTRN12626000342314